Recent Comments

Comment RSS

Bird Flu News and Research RSS Feed - Bird Flu News and Research Twitter

Why avian flu virus has not caused a pandemic?

19. November 2009 05:01
Bird flu viruses would have to make at least two simultaneous genetic mutations before they could be transmitted readily from human to human, according to research published today in PLoS ONE. [More]

Posted in: Disease/Infection News

Tags: , , , , , , ,

Special report on past influenza pandemics and recent virus scares

17. November 2009 05:18
Research and Markets (http://www.researchandmarkets.com/research/5ec1bd/special_report_th) has announced the addition of Decision Resources, Inc.'s new report "Special Report: The Pandemic Paradigm: Balancing Commercial Opportunities with Public Health Concerns in the Face of A/H1N1 2009" to their offering. [More]

Posted in: Disease/Infection News

Tags: , , , , , , , , , ,

In-depth information of the American, European and Japanese pharmaceutical markets

11. November 2009 05:55
Reportlinker.com announces that a new market research report is available in its catalogue: Pharmaceutical Pricing, Reimbursement and Parallel Trade 2006 [More]

NanoViricides to present data on its in vivo studies against influenza

9. November 2009 08:14
NanoViricides, Inc., announced today that the Company’s CEO, Eugene Seymour, MD, MPH, has been invited to participate in a panel discussion at the Influenza Congress USA 2009, in Washington DC on November 19th (www.terrapinn.com/usaflu). The discussion will center on the “Evolving Role of Anti-Virals” in influenza treatment. [More]

Posted in: Medical Research News | Disease/Infection News

Tags: , , , , , , , ,

SDC-based hard surface disinfectant is effective against the 2009 H1N1

27. October 2009 09:50
PURE Bioscience, creators of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that its SDC-based hard surface disinfectant is effective against the 2009 H1N1 and is included on the list published by the U.S. Environmental Protection Agency (EPA) of antimicrobial products effective against the 2009 H1N1 flu strain based on their effectiveness against other influenza A virus strains. [More]

New anti-flu drugs to fight flu virus could become a reality

27. October 2009 06:46
New anti-flu drugs could become a reality as a result of a study carried out by academics at the University of Hertfordshire. [More]

Posted in: Disease/Infection News | Pharmaceutical News

Tags: , , ,

Anti-viral drug development programs progress successfully, reports NanoViricides

26. October 2009 07:40
NanoViricides, Inc. (the "Company"), reports that the Company is well financed and its game changing anti-viral drug development programs are progressing successfully. As such, Management knows of no reason for the recent decline in stock price and associated volatility. [More]

Wildlife Conservation Society to monitor diseases for preventing global pandemic

24. October 2009 06:53
The Wildlife Conservation Society will play a key role in a new international effort to monitor diseases that move between animals and people in order to prevent the next global pandemic. [More]

Posted in: Disease/Infection News

Tags: , , , , , , , ,

UC Davis' international effort to prevent new pandemics

24. October 2009 05:58
In hopes of preventing the next global pandemic and a possible death toll into the millions, UC Davis today launches an unprecedented international effort to find and control diseases that move between wildlife and people. [More]

Posted in: Disease/Infection News

Tags: , , , , , , , ,

Aethlon Hemopurifier effective in capturing H1N1 Swine Flu Virus

21. October 2009 06:44
Aethlon Medical, Inc. announced today that research studies have documented the Aethlon Hemopurifier® is effective in capturing the current pandemic strain of the H1N1 Swine Flu Virus. The Hemopurifier® is the first-in-class medical device able to selectively remove infectious viruses and immunosuppressive proteins from the bloodstream. [More]

Rice University scientists win NIH stimulus funds to study influenza A

21. October 2009 00:17
Rice University scientists have won a $1.5 million grant from the National Institutes of Health to scrutinize the influenza A virus for clues that could lead to more effective antiviral drugs. Strains of influenza A include this year's pandemic H1N1 variety, some seasonal varieties and the much-feared H5N1 bird flu. [More]

Posted in: Disease/Infection News

Tags: , , , , , , , ,

Sinovac Biotech announces receipt of Panflu vaccine distribution approval in Hong Kong

14. October 2009 05:39
Sinovac Biotech Ltd., a leading developer and provider of vaccines in China, announced today that its wholly-owned subsidiary, Sinovac Biotech (Hong Kong) Ltd, has received the Certificate of Approval to distribute Panflu(TM) (H5N1), its H5N1 (bird flu) pandemic influenza vaccine, in Hong Kong. The certificate is valid through September 13, 2014 and thereafter will be renewable for periods of five years at a time, subject to payment of the registration fee. [More]

Posted in: Pharmaceutical News

Tags: , , , , , ,

NanoViricides completes a number of financing activities

5. October 2009 07:35
NanoViricides, Inc. (the "Company"), announced today that it has completed a number of financing activities. [More]

Posted in: Business / Finance

Tags: , , , , , , ,

The Replikin Count of H1N1 virus’s infectivity gene shows continued elevation

30. September 2009 09:11
The latest H1N1 genomic data shows a 50% drop in the Replikin CountTM of the virus’s replikins lethality gene since its recorded highs in April 2009. In contrast, the Replikin Count of the virus’s infectivity gene showed a continued elevation. [More]

Posted in: Medical Science News | Disease/Infection News

Tags: , , , , , , , , ,

Aphios awarded NIH grant to develop pathogen inactivation technology for blood products

30. September 2009 08:55
Aphios Corporation today announced that it has been awarded a RC-1 Challenge grant (No. 1RC1HL102822-01) from the National Heart, Lung, and Blood Institute (NHLBI), National Institute of Health’s (NIH) American Recovery and Reinvestment Act (ARRA) funds to develop a generally-applicable pathogen inactivation technology for blood products. [More]

Posted in: Device / Technology News | Disease/Infection News

Tags: , , , , , , , , ,

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.